https://alsnewstoday.com/news/lithium-valproic-acid-combo-may-slow-als-progression-trial/
A small pilot trial in ALS patients found VPA-Li, oral combination of lithium and valproic acid, showed potential to slow functional decline.
Create an account or login to join the discussion